Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT LLC | 02-14-2024 | 12-31-2023 | 67 | 335,961,131 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| Akero Therapeutics Inc | EQUITIES | 51 | $5,820,081 | 249,254 | 0.00 | 0.00 | 217,918 | 695.42 | 12-31-2023 |
| Pliant Therapeutics Inc | EQUITIES | 52 | $5,768,470 | 318,524 | 0.00 | 0.00 | 68,115 | 27.20 | 12-31-2023 |
| Intra-Cellular Therapies Inc | EQUITIES | 53 | $5,729,600 | 80,000 | 0.00 | 0.00 | -128,730 | -61.67 | 12-31-2023 |
| Cogent Biosciences Inc | EQUITIES | 54 | $5,684,478 | 966,748 | 0.00 | 0.00 | 315,376 | 48.42 | 12-31-2023 |
